Revenue: The sum of all revenue fields included for a company's operating activities.
Hemab Therapeutics Holdings, Inc. (COAG) Revenue data is not available.
| Income Statement Financials | |
|
Revenue |
-- |
$-22.69M |
|
-- |
|
-- |
|
$23.61M |
|
$-23.61M |
|
$0.94M |
|
$-22.68M |
|
$-22.68M |
|
$-22.69M |
|
$-22.69M |
|
$-22.69M |
|
$-22.69M |
|
$-23.61M |
|
$-23.54M |
|
0.95M |
|
0.95M |
|
$-23.98 |
|
$-23.98 |
|
| Balance Sheet Financials | |
$169.43M |
|
$0.65M |
|
$5.83M |
|
$175.26M |
|
$13.19M |
|
-- |
|
$360.69M |
|
$373.88M |
|
$-198.62M |
|
$-198.62M |
|
$-198.62M |
|
0.95M |
|
| Cash Flow Statement Financials | |
$-21.58M |
|
$-15.85M |
|
$-0.46M |
|
$87.97M |
|
$49.86M |
|
$-38.11M |
|
$1.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.85 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-21.70M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
11.42% |
|
11.42% |
|
-12.94% |
|
11.42% |
|
$-209.96 |
|
$-22.93 |
|
$-22.82 |
|